KLRK1 and neoplasm: Dacarbazine (DTIC) is a chemotherapeutic agent widely used in treating melanoma that works by the upregulation of NKG2D ligands on tumour cells, which activates NKs and CTLs, thereby eliciting antitumour immune responses.